The malignant transformation of liver cell adenomas
J. H. Foster and M. M. Berman
Department of Surgery, University of Connecticut Health Center, Farmington.
OBJECTIVE: To investigate clinical experience with the apparent malignant
transformation of benign liver cell adenomas. DESIGN: Retrospective review
of personal experience and literature. SETTING: University hospital and
affilated community hospitals. PATIENTS: All patients diagnosed with liver
cell adenomas over a 30-year period. INTERVENTIONS: Liver resection and/or
tumor biopsy. MAIN OUTCOME MEASURES: Gender, age, drug associations,
alpha-fetoprotein levels, response to treatment, and survival. RESULTS:
Thirteen patients from personal experience and 26 patients from the reports
of others had liver cell adenomas that were not resected. Five of these
patients subsequently developed hepatocellular carcinoma. CONCLUSIONS:
Malignant transformation of a liver cell adenoma is a rare phenomenon, but
it does occur. Alpha-fetoprotein levels may be more helpful in diagnosis
than expected from previous reports. Solitary benign adenomas should be
resected whenever possible. Patients with diffuse multiple tumors should be
observed closely over a long period.
Surgical Management of Hepatocellular Adenoma: Take It or Leave It?
Cho et al.
Ann. Surg. Oncol. 2008;15:2795-2803.
ABSTRACT
| FULL TEXT
Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine-enhanced MR Imaging: Prospective Study
Grazioli et al.
Radiology 2005;236:166-177.
ABSTRACT
| FULL TEXT
Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation Profiling
Lehmann et al.
Clin. Cancer Res. 2005;11:3654-3660.
ABSTRACT
| FULL TEXT
Successful Treatment of Hepatocellular Adenoma with Percutaneous Radiofrequency Ablation
Atwell et al.
Am. J. Roentgenol. 2005;184:828-831.
ABSTRACT
| FULL TEXT
Hepatocyte Nuclear Factor-1{alpha} Gene Inactivation: Cosegregation between Liver Adenomatosis and Diabetes Phenotypes in Two Maturity-Onset Diabetes of the Young (MODY)3 Families
Reznik et al.
J. Clin. Endocrinol. Metab. 2004;89:1476-1480.
ABSTRACT
| FULL TEXT
INK4a-ARF alterations in liver cell adenoma
Tannapfel et al.
Mol. Pathol. 2002;55:379-384.
ABSTRACT
| FULL TEXT
INK4a-ARF alterations in liver cell adenoma
Tannapfel et al.
Gut 2002;51:253-258.
ABSTRACT
| FULL TEXT
Indications and Long-term Outcome of Treatment for Benign Hepatic Tumors: A Critical Appraisal
Terkivatan et al.
Arch Surg 2001;136:1033-1038.
ABSTRACT
| FULL TEXT
Hepatic Adenomas: Imaging and Pathologic Findings
Grazioli et al.
RadioGraphics 2001;21:877-892.
ABSTRACT
| FULL TEXT
Invited Commentary
Levy and Ros
RadioGraphics 2001;21:892-894.
FULL TEXT
Hepatocellular Adenoma: Multiphasic CT and Histopathologic Findings in 25 Patients
Ichikawa et al.
Radiology 2000;214:861-868.
ABSTRACT
| FULL TEXT
CT and MR Imaging of Benign Hepatic and Biliary Tumors
Horton et al.
RadioGraphics 1999;19:431-451.
ABSTRACT
| FULL TEXT